ORCHESTRA BIOMED HOLDINGS, INC. (OBIO)
Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement
Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement
IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences
ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth
VisionWave Accelerates Operational Integration of Patent-Protected AI Platform: Deploying xCalibre™ Neuro-Logic IP Across Solar Drone’s Autonomous Flight Platforms
Novavax Reports First Quarter 2026 Financial Results and Operational Highlights
LightInTheBox to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026
Cimpress to Participate in Upcoming Investor Conferences
Roots Showcases Summer 2026 Collections
SmartRent Reports First Quarter 2026 Financial Results
Aktis Oncology to Present at the BofA Securities Health Care Conference